Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

Result of AGM

6 Sep 2012 09:41

RNS Number : 6458L
J.P. Morgan Private Equity Ltd
06 September 2012
Β 

Β 

JPEL ANNOUNCES RESULTS OF AGM AND CLASS MEETINGS

Β 

* * *

Β 

GUERNSEY, 6 SEPTEMBER 2012

Β 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company") is pleased to announce that at the Annual General Meeting ("AGM") of the Company held on 5 September 2012, all resolutions put to shareholders were duly passed. In addition, the resolutions proposed at separate class meetings of US$ Equity Shareholders, 2013 ZDP Shareholders, 2015 ZDP Shareholders and 2017 ZDP Shareholders were duly passed.

Β 

In particular, JPEL's Board of Directors (the "Board") is pleased to announce that a special resolution was passed at the AGM which will allow the Company to:

Β·; Amend the limit on borrowing to 30 per Cent. of the Total Assets of the Company.

Β·; Amend the final capital entitlement dates of each of the Company's three classes of ZDP Shares. Each final capital entitlement date will be moved forward by two months, and each final capital entitlement will remain the same.

Β·; Increase the minimum cover under the ZDP Test from 1.3 times to 2.0 times, as defined in the Company's Articles.

Β 

JPEL's Board is focused on the optimisation of the Company's capital structure. The Board believes that the combination of all ordinary, special and extraordinary resolutions passed at the AGM and the Class Meetings provide JPEL with maximum flexibility to efficiently manage its capital structure.

Β 

Unless otherwise defined in this announcement, defined terms shall have the meeting given to them in the circular issued by the Company dated 23 July 2012.

Β 

Β 

* * *

Β 

SUMMARY OF RESOLUTIONS PASSED AT JPEL'S AGM

Β 

Special Resolutions

Β 

1. To renew the Company's authority to make purchases of up to 15 per cent. of its own issued Shares pursuant to any proposed Tender Offer;

2. To renew the Company's general authority to make market purchases of up to 14.99 per cent. of its own issued Shares;

3. To renew the disapplication of the pre-emption rights for up to 10 per cent. of its own issued Shares as set out in the Articles of Incorporation;

4. To (i) amend the Company's borrowing powers to 30 per cent. of Total Assets from 20 per. cent of Adjusted Total of Capital and Reserves as set out in the Articles of Incorporation and to further amend the Articles of Incorporation to incorporate the rights of the 2017 ZDP Shares, (ii) amend the final capital entitlement date of each class of Issued ZDP Shares, (iii) amend the ZDP Test, and (iv) make a corresponding change to the borrowing restriction contacted in the investment policy.

Β 

Ordinary Resolutions

Β 

5. To approve and adopt the Annual Report and Financial Statements of the Company for the year ended 30 June 2011;

6. To re-elect Gregory S. Getschow as a non-executive Director of the Company, who retires by rotation;

7. To re-elect John Loudon as a non-executive, independent Director of the Company, who retires by rotation;

8. To elect PricewaterhouseCoopers CI LLC as Auditors to the Company;

9. To authorise the Directors to determine the Auditors' remuneration; and

10. To authorise and agree the remuneration of Directors in accordance with the Articles of Incorporation.

Β 

SUMMARY OF RESOLUTIONS PASSED AT THE CLASS MEETING OF US$ EQUITY SHAREHOLDERS

Β 

Extraordinary Resolution - US$ Equity Shares

Β 

1. To (i) amend the Company's borrowing powers to 30 per cent. of Total Assets from 20 per. cent of Adjusted Total of Capital and Reserves as set out in the Articles of Incorporation and to further amend the Articles of Incorporation to incorporate the rights of the 2017 ZDP Shares, (ii) amend the final capital entitlement date of each class of Issued ZDP Shares, (iii) amend the ZDP Test, and (iv) make a corresponding change to the borrowing restriction contacted in the investment policy.

Β 

Ordinary Resolution - US$ Equity Shares

Β 

2. To approve the Refinancing Proposal formulated by the Board.

Β 

SUMMARY OF THE RESOLUTION PASSED AT EACH SEPARATE CLASS MEETING OF 2013 ZDP SHAREHOLDERS, 2015 ZDP SHAREHOLDERS AND 2017 ZDP SHAREHOLDERS

Β 

Β 

Extraordinary Resolution - ZDP Shares

Β 

To (i) amend the Company's borrowing powers to 30 per cent. of Total Assets from 20 per. cent of Adjusted Total of Capital and Reserves as set out in the Articles of Incorporation and to further amend the Articles of Incorporation to incorporate the rights of the 2017 ZDP Shares, (ii) amend the final capital entitlement date of each class of Issued ZDP Shares, (iii) amend the ZDP Test, and (iv) make a corresponding change to the borrowing restriction contacted in the investment policy.

Β 

* * *

Β 

A copy of the special and extraordinary resolutions has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do.

Β 

Β 

* * *

Β 

About J.P. Morgan Private Equity Limited

Β 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPEZ, JPZZ, JPSZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market. On 17 August 2009, JPEL issued warrants free of subscription cost to shareholders on record. The warrants are publicly traded on the London Stock Exchange under the symbol "JPWW."

Β 

END

Β 

For further information please contact:

Β 

J.P. Morgan Private Equity Limited

Troy Duncan / Greg Getschow

Troy.Duncan@jpmorgan.com / Gregory.Getschow@jpmorgan.com

Β 

Rosemary DeRise / Samantha Ladd

+1 212 648 2980 / +1 212 648 2982

Rosemary.DeRise@jpmorgan.com / Samantha.Ladd@jpmorgan.com

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RAGLFMPTMBJMMRT
Date   Source Headline
2nd Jun 20269:29 amRNSNet Asset Value - March 2026
23rd Apr 20267:00 amRNSJoint Broker Appointment
14th Apr 20267:00 amRNSAppointment of Directors
6th Mar 20265:59 pmRNSHalf-year Financial Report - December 2025
14th Jan 20269:53 amRNSCOMPLETION OF THIRTEENTH MANDATORY REDEMPTION
29th Dec 20253:18 pmRNSTHIRTEENTH MANDATORY REDEMPTION
19th Dec 20255:53 pmRNSNet Asset Value September 2025
2nd Dec 20254:44 pmRNS2025 AGM Results Statement
10th Nov 202512:19 pmRNS2025 AGM Circular Statement
5th Nov 20254:07 pmRNSHolding(s) in Company
3rd Nov 20254:30 pmRNSHolding(s) in Company
3rd Nov 20254:11 pmRNSHolding(s) in Company
30th Oct 20257:00 amRNSAnnual Financial Report 2025
22nd Jul 20257:00 amRNSAppointed Sole Corp. Broker & Financial Adviser
10th Jun 20254:47 pmRNSNet Asset Value - March 2025
1st May 20256:11 pmRNSHolding(s) in Company
18th Mar 20255:04 pmRNSHalf-year Report - December 2024
3rd Dec 20242:30 pmRNSNet Asset Value September 2024
27th Nov 20245:16 pmRNS2024 AGM Results
6th Nov 20247:00 amRNS2024 AGM Circular
25th Oct 20247:00 amRNSPortfolio Update
25th Oct 20247:00 amRNSAnnual Financial Report - 2024
5th Jun 20247:00 amRNSNet Asset Value - March 2024
23rd Apr 20245:18 pmRNSDirector Declaration
15th Mar 20246:15 pmRNSNet Asset Value - December 2023
15th Mar 20246:03 pmRNSHalf-year Report - December 2023
15th Mar 20243:50 pmRNSHalf-year Report - 2023
6th Dec 20235:36 pmRNSDirector Declaration
6th Dec 20235:33 pmRNSAGM RESULTS 2023
9th Nov 202311:56 amRNS2023 AGM CIRCULAR
8th Nov 20237:00 amRNSCompletion of Twelfth Mandatory Redemption
24th Oct 20237:00 amRNSTwelfth Mandatory Redemption & Shareholder Update
20th Oct 202310:28 amRNSNet Asset Value - September 2023
21st Sep 20235:33 pmRNSNet Asset Value(s) - June 2023
21st Jun 20233:36 pmRNSDirectorate Change
12th May 20231:46 pmRNSNet Asset Value(s) - March 2023
28th Mar 20233:32 pmRNSHalf-year Report - 31 December 2022
14th Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 202311:05 amRNSSecond Price Monitoring Extn
14th Mar 202311:00 amRNSPrice Monitoring Extension
14th Mar 20239:05 amRNSSecond Price Monitoring Extn
14th Mar 20239:00 amRNSPrice Monitoring Extension
24th Feb 20234:22 pmRNSNet Asset Value(s) - December 2022
13th Feb 20234:51 pmRNSDirector Declaration
22nd Dec 20227:00 amRNSCompletion of Eleventh Mandatory Redemption
14th Dec 20227:00 amRNSELEVENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE
13th Dec 20225:09 pmRNSDirectorate Change
29th Nov 20224:33 pmRNSAGM Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.